Antipsychotic Drug Stabilization Period For Long-Term Studies Can Be Short, Vanda Pharma Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Patient response periods in past studies have been as short as one month, the antipsychotic drug developer maintains in briefing materials for Oct. 25 meeting of psychopharmacologic advisory committee.
You may also be interested in...
Wyeth Set To File NDA For Antipsychotic Bifeprunox In 2006
Wyeth has partnered with Solvay to structure a development plan for the atypical antipsychotic.
Wyeth Set To File NDA For Antipsychotic Bifeprunox In 2006
Wyeth has partnered with Solvay to structure a development plan for the atypical antipsychotic.
Zyprexa Ekes Out Narrow Lead In Schizophrenia Study, But Efficacy Is Offset By Side Effects
CATIE study finds no significant difference in effectiveness between conventional antipsychotic perphenazine and three atypicals: AstraZeneca’s Seroquel, J&J’s Risperdal and Pfizer’s Geodon.